Zobrazeno 1 - 10
of 77
pro vyhledávání: '"Marc Diltoer"'
Autor:
Wim Jonckheere, Michaël Mekeirele, Steven Hendrickx, Joop Jonckheer, Marc Diltoer, Idris Ghijselings, Matthias Raes, Domien Vanhonacker, Manu L.G. Malbrain, Ina Foulon, Frans Gordts, Daniel Jacobs-Tulleneers-Thevissen, Mark La Meir, Jan Nijs, Dirk Smets, Martijn Schoneveld, Ellen Van Eetvelde, Marian Vanhoeij, Katia Verbruggen, Guy Verfaillie, Paul Wischmeyer, Elisabeth De Waele
Publikováno v:
Anaesthesiology Intensive Therapy, Vol 52, Iss 5, Pp 366-372 (2020)
Externí odkaz:
https://doaj.org/article/6be24d4185ff46fb9ddd36965dcd59ce
Autor:
Joop Jonckheer, Herbert Spapen, Aziz Debain, Joy Demol, Marc Diltoer, Olivier Costa, Katrien Lanckmans, Taku Oshima, Patrick M. Honoré, Manu Malbrain, Elisabeth De Waele
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-6 (2019)
Abstract Background Carbon dioxide (CO2) accumulation is a challenging issue in critically ill patients. CO2 can be eliminated by renal replacement therapy but studies are scarce and clinical relevance is unknown. We prospectively studied CO2 and O2
Externí odkaz:
https://doaj.org/article/82c6118a954244df889e564aaa368565
Publikováno v:
BMC Nephrology, Vol 21, Iss 1, Pp 1-1 (2020)
Following publication of the original article [1], we have been notified that the approved number by the Ethical Committee was given incorrectly. In the section “Methods” stated that: The Central Ethical Committee of the University Hospital appro
Externí odkaz:
https://doaj.org/article/d9dfeb8386ba42819b79d068aa63108b
Autor:
Herbert Spapen, Marianne Borremans, Marc Diltoer, Viola Van Gorp, Duc Nam Nguyen, Patrick M Honoré
Publikováno v:
Journal of Anaesthesiology Clinical Pharmacology, Vol 30, Iss 1, Pp 65-70 (2014)
Background: Few studies have investigated high-frequency percussive ventilation (HFPV) in adult patients with acute respiratory distress syndrome (ARDS). Materials and Methods: We retrospectively analyzed data from critically ill-patients with moder
Externí odkaz:
https://doaj.org/article/76e4329b63f743dabcff5f073b565664
Autor:
Joop Jonckheer, Herbert Spapen, Aziz Debain, Joy Demol, Marc Diltoer, Olivier Costa, Katrien Lanckmans, Taku Oshima, Patrick M. Honoré, Manu Malbrain, Elisabeth De Waele
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-1 (2019)
Externí odkaz:
https://doaj.org/article/693a6300d89d445fb6df95cfd2039c56
Autor:
George R Thompson, Alex Soriano, Oliver A Cornely, Bart Jan Kullberg, Marin Kollef, Jose Vazquez, Patrick M Honore, Matteo Bassetti, John Pullman, Methee Chayakulkeeree, Ivan Poromanski, Cecilia Dignani, Anita F Das, Taylor Sandison, Peter G Pappas, Murat Akova, Rawan AlAgha, George Alangaden, Svenja J Albrecht, Barbara Alexander, Mohanad Al-Obaidi, German Ambasch, Fernando Armestar Rodriguez, Alpay Azap, Anthony Baffoe-Bonnie, Leila Belkhir, Ronen Ben-Ami, David Boutoille, Antonio Cascio, Louis YA Chai, Romanee Chaiwarith, Sharon Chen, Yee-Chun Chen, Yen-Hsu Chen, Jun Yong Choi, Young Hwa Choi, Darunee Chotiprasitsakul, Jin Won Chung, François Danion, Blandine Denis, Emilio Diaz Santos, Miguel O Dictar, Marc Diltoer, Herve Dupont, Sizhou Feng, Maria Angeles Ferre Colomer, Ricard Ferrer, Jean-Marie Fernand Roger Forel, Jesús Fortún-Abete, Julia Garcia-Diaz, Massimo Girardis, Fang He, Maya Hites, Mao-Wang Ho, Patrick Honore, Juan Pablo Horcajada Gallego, Haihui Huang, Po-Yen Huang, Yong Huang, Osamah Hussein, Poj Intalapaporn, Sutep Jaruratanasirikul, Luis Jauregui-Peredo, Misty Johnson, Dong Sik Jung, Kamonwan Jutivorakool, Winfried V Kern, Daniel H Kett, Thana Khawcharoenporn, Young Keun Kim, Philipp Koehler, Anastasia Kotanidou, Anne Lachiewicz, Qinhan Lin, Luis Eduardo Lopez Cortes, Hong Luo, Roberto Luzzati, Yasmin Maor, Todd McCarty, Maria Merelli, Paloma Merino Amador, John Midturi, Guglielmo Marco Migliorino, Jean-Paul Mira, Piroon Mootsikapun, Orla Morrissey, Patricia Munoz Garcia de Paredes, Cristina Mussini, Eleftherios Mylonakis, Saadalla Nseir, William Nseir, Zekaver Odabasi, Vasileios Papastamopoulos, David Paterson, Thomas F Patterson, Kyong Ran Peck, Zhiyong Peng, Nitipong Permpalung, Gaetan J Plantefeve, Ivan G Poromanski, Debra Powell, Mina Psichogiou, Ser Hon Puah, Galia Rahav, Antonio Ramos Martinez, Juan Carlos Ramos Ramos, Ayelet Raz-Pasteur, Carlos A Restrepo Castro, Fernando Riera, France Roblot, Regino Jose Rodriguez Alvarez, Benjamin Rogers, Emmanuel Roilides, Gregorio Sanchez Vallejo, Gabriele Sganga, Nikolaos Sipsas, Monica Slavin, Andrej Spec, Jacob Strahilevitz, Dora M Tancheva, Zhen Tao, Daniel Teschner, Eric Van Wijngaerden, Paschalis Vergidis, Pierluigi Viale, Fu-Der Wang, Shifu Wang, Gabriel Weber, Jianyu Weng, Jinfu Xu, Li Yao, Serap Yavuz, Mesut Yilmaz, Jo-Anne Young, Abel H Zarate, Jun Zeng, Yong Zhang
Publikováno v:
Lancet, Vol. 401, no. 10370, p. 49-59 (2023)
The Lancet (London), 401, 49-59
The Lancet (London), 401, 10370, pp. 49-59
Lancet, p. [1-11] (2022)
The Lancet (London), 401, 49-59
The Lancet (London), 401, 10370, pp. 49-59
Lancet, p. [1-11] (2022)
Item does not contain fulltext BACKGROUND: Rezafungin is a next-generation, once-a-week echinocandin in development for the treatment of candidaemia and invasive candidiasis and for the prevention of invasive fungal disease caused by Candida, Aspergi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d232fde8055f33c79f2f4b250c2a2249
https://doi.org/10.1016/S0140-6736(22)02324-8
https://doi.org/10.1016/S0140-6736(22)02324-8
Autor:
Alexander P J Vlaar, Martin Witzenrath, Pieter van Paassen, Leo M A Heunks, Bruno Mourvillier, Sanne de Bruin, Endry H T Lim, Matthijs C Brouwer, Pieter R Tuinman, José F K Saraiva, Gernot Marx, Suzana M Lobo, Rodrigo Boldo, Jesus A Simon-Campos, Alexander D Cornet, Anastasia Grebenyuk, Johannes M Engelbrecht, Murimisi Mukansi, Philippe G Jorens, Robert Zerbib, Simon Rückinger, Korinna Pilz, Renfeng Guo, Diederik van de Beek, Niels C Riedemann, Alexander P.J. Vlaar, Leo M.A. Heunks, Endry H.T. Lim, Matthijs C. Brouwer, Pieter R. Tuinman, José Francisco K. Saraiva, Suzana Lobo, Jesus Simon-Campos, Alexander D. Cornet, Johannes Engelbrecht, Philippe G. Jorens, Niels C. Riedemann, Pierre Bulpa, Fabio S. Taccone, Greet Hermans, Marc Diltoer, Michael Piagnerelli, Nikolaas De Neve, Antonio T. Freire, Felipe D. Pizzol, Anna Karolina Marinho, Victor H. Sato, Clovis Arns da Cunha, Mathilde Neuville, Jean Dellamonica, Djillali Annane, Antoine Roquilly, Jean Luc Diehl, Francis Schneider, Jean Paul Mira, Jean Baptiste Lascarrou, Luc Desmedt, Claire Dupuis, Carole Schwebel, Guillaume Thiéry, Matthias Gründling, Marc Berger, Tobias Welte, Michael Bauer, Ulrich Jaschinski, Klaus Matschke, Roberto Mercado-Longoria, Belinda Gomez Quintana, Jorge Alberto Zamudio-Lerma, Juan Moreno Hoyos Abril, Angel Aleman Marquez, Peter Pickkers, Luuk Otterspoor, Luis Hercilla Vásquez, Carlos Rafael Seas Ramos, Alejandro Peña Villalobos, Gonzalo Gianella Malca, Victoria Chávez, Victor Filimonov, Vladimir Kulabukhov, Pinak Acharya, Sjoerd A.M.E.G. Timmermans, Matthias H. Busch, Floor L.F. van Baarle, Rutger Koning, Liora ter Horst, Nora Chekrouni, Thijs M. van Soest, Marleen A. Slim, Lonneke A. van Vught, Rombout B.E. van Amstel, Sabine E. Olie, Ingeborg E. van Zeggeren, Marcel C.G. van de Poll, Claus Thielert, Dorothee Neukirchen
Publikováno v:
The Lancet Respiratory medicine, 10(12), 1137-1146. ELSEVIER SCI LTD
Lancet respiratory medicine, 10(12), 1137-1146. Elsevier Limited
Lancet Respiratory Medicine, 10, 12, pp. 1137-1146
The lancet respiratory medicine
PANAMO study group 2022, ' Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO) : a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial ', Lancet respiratory medicine, vol. 10, no. 12, pp. 1137-1146 . https://doi.org/10.1016/S2213-2600(22)00297-1
lancet. Respiratory medicine, 10(12), 1137-1146. Elsevier Limited
Lancet Respiratory Medicine, 10, 1137-1146
Lancet respiratory medicine, 10(12), 1137-1146. Elsevier Limited
Lancet Respiratory Medicine, 10, 12, pp. 1137-1146
The lancet respiratory medicine
PANAMO study group 2022, ' Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO) : a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial ', Lancet respiratory medicine, vol. 10, no. 12, pp. 1137-1146 . https://doi.org/10.1016/S2213-2600(22)00297-1
lancet. Respiratory medicine, 10(12), 1137-1146. Elsevier Limited
Lancet Respiratory Medicine, 10, 1137-1146
Contains fulltext : 287661.pdf (Publisher’s version ) (Closed access) BACKGROUND: Vilobelimab, an anti-C5a monoclonal antibody, was shown to be safe in a phase 2 trial of invasively mechanically ventilated patients with COVID-19. Here, we aimed to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f8ba6e900c408360d398f60555ae06e
https://cris.maastrichtuniversity.nl/en/publications/bd6096d8-38fc-4032-bed0-e61be7ec1575
https://cris.maastrichtuniversity.nl/en/publications/bd6096d8-38fc-4032-bed0-e61be7ec1575
Autor:
Marc Diltoer, Patrick M. Honore, Manu L N G Malbrain, Joop Jonckheer, Elisabeth De Waele, Katrien Lanckmans, Herbert D. Spapen, Taku Oshima, J. Demol, Olivier Costa, Aziz Debain
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-6 (2019)
BMC Nephrology
BMC Nephrology
Background Carbon dioxide (CO2) accumulation is a challenging issue in critically ill patients. CO2 can be eliminated by renal replacement therapy but studies are scarce and clinical relevance is unknown. We prospectively studied CO2 and O2 behavior
Autor:
Duc Nam Nguyen, Elisabeth De Waele, Herbert D. Spapen, Annelies Maurits Meuwissen, Mark La Meir, Manu L N G Malbrain, Robert A. Wise, Marc Diltoer, Tina Maes
Publikováno v:
Journal of Critical Care. 49:129-135
Introduction Standardized protocols are provided for maintenance and replacement fluid therapy in critically ill patients. However, unintended fluid sources (analgesics, antibiotics and other drugs) are not always taken into account when prescribing
Ganesh pilot study: The evolution of metabolism during different levels of NIV in healthy volunteers
Autor:
Peter van Londersele, Olivier Costa, Joop Jonckheer, Domien Vanhonacker, Marc Diltoer, Michaël Mekeirele, Elisabeth De Waele
BackgroundMetabolism of critically ill adult patients is variable and influenced by intrinsic and extrinsic factors. Energy expenditure and thereby metabolism can be captured with indirect calorimetry (IC). An increased respiratory muscle use due to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::055d01e6421a6d0511aa49800603b6d7
https://doi.org/10.21203/rs.3.rs-274437/v1
https://doi.org/10.21203/rs.3.rs-274437/v1